Journal of the European Academy of Dermatology and Venereology· 2012Q1· Guideline
Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
- 682citations
- Q1SCImago
- 2012year
Short summary
Topical corticosteroids remain the mainstay for atopic eczema (AE) exacerbations, but topical calcineurin inhibitors (TCIs) like tacrolimus and pimecrolimus are preferred for specific locations, with systemic immunosuppressants reserved for severe refractory cases.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Dermatology
DermatologyMedicine